These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29736028)

  • 1. PM20D1 is a quantitative trait locus associated with Alzheimer's disease.
    Sanchez-Mut JV; Heyn H; Silva BA; Dixsaut L; Garcia-Esparcia P; Vidal E; Sayols S; Glauser L; Monteagudo-Sánchez A; Perez-Tur J; Ferrer I; Monk D; Schneider B; Esteller M; Gräff J
    Nat Med; 2018 May; 24(5):598-603. PubMed ID: 29736028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of PM20D1 QTL in Alzheimer's disease.
    Sanchez-Mut JV; Glauser L; Monk D; Gräff J
    Clin Epigenetics; 2020 Feb; 12(1):20. PubMed ID: 32014019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
    Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
    Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancer variants associated with Alzheimer's disease affect gene expression via chromatin looping.
    Kikuchi M; Hara N; Hasegawa M; Miyashita A; Kuwano R; Ikeuchi T; Nakaya A
    BMC Med Genomics; 2019 Sep; 12(1):128. PubMed ID: 31500627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mendelian randomization integrating GWAS and mQTL data identified novel pleiotropic DNA methylation loci for neuropathology of Alzheimer's disease.
    Liu D; Wang Y; Jing H; Meng Q; Yang J
    Neurobiol Aging; 2021 Jan; 97():18-27. PubMed ID: 33120085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer's disease.
    Gjoneska E; Pfenning AR; Mathys H; Quon G; Kundaje A; Tsai LH; Kellis M
    Nature; 2015 Feb; 518(7539):365-9. PubMed ID: 25693568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels.
    Maxwell TJ; Corcoran C; Del-Aguila JL; Budde JP; Deming Y; Cruchaga C; Goate AM; Kauwe JSK;
    Alzheimers Res Ther; 2018 Aug; 10(1):86. PubMed ID: 30153862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A screen of 1,049 schizophrenia and 30 Alzheimer's-associated variants for regulatory potential.
    Myint L; Wang R; Boukas L; Hansen KD; Goff LA; Avramopoulos D
    Am J Med Genet B Neuropsychiatr Genet; 2020 Jan; 183(1):61-73. PubMed ID: 31503409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic loci modulating amyloid-beta levels in a mouse model of Alzheimer's disease.
    Ryman D; Gao Y; Lamb BT
    Neurobiol Aging; 2008 Aug; 29(8):1190-8. PubMed ID: 17400334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease.
    Huang KL; Marcora E; Pimenova AA; Di Narzo AF; Kapoor M; Jin SC; Harari O; Bertelsen S; Fairfax BP; Czajkowski J; Chouraki V; Grenier-Boley B; Bellenguez C; Deming Y; McKenzie A; Raj T; Renton AE; Budde J; Smith A; Fitzpatrick A; Bis JC; DeStefano A; Adams HHH; Ikram MA; van der Lee S; Del-Aguila JL; Fernandez MV; Ibañez L; ; ; Sims R; Escott-Price V; Mayeux R; Haines JL; Farrer LA; Pericak-Vance MA; Lambert JC; van Duijn C; Launer L; Seshadri S; Williams J; Amouyel P; Schellenberg GD; Zhang B; Borecki I; Kauwe JSK; Cruchaga C; Hao K; Goate AM
    Nat Neurosci; 2017 Aug; 20(8):1052-1061. PubMed ID: 28628103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Key Long Non-Coding RNAs in the Pathology of Alzheimer's Disease and their Functions Based on Genome-Wide Associations Study, Microarray, and RNA-seq Data.
    Han Z; Xue W; Tao L; Zhu F
    J Alzheimers Dis; 2019; 68(1):339-355. PubMed ID: 30776002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data integration for functional annotation of regulatory single nucleotide polymorphisms associated with Alzheimer's disease susceptibility.
    Amber S; Zahid S
    Gene; 2018 Sep; 672():115-125. PubMed ID: 29883757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating Alzheimer's disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs.
    Katsumata Y; Nelson PT; Estus S; ; Fardo DW
    Neurobiol Aging; 2019 Feb; 74():135-146. PubMed ID: 30448613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease.
    Laws SM; Friedrich P; Diehl-Schmid J; Müller J; Eisele T; Bäuml J; Förstl H; Kurz A; Riemenschneider M
    Mol Psychiatry; 2007 May; 12(5):510-7. PubMed ID: 17179995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.
    Jansen IE; Savage JE; Watanabe K; Bryois J; Williams DM; Steinberg S; Sealock J; Karlsson IK; Hägg S; Athanasiu L; Voyle N; Proitsi P; Witoelar A; Stringer S; Aarsland D; Almdahl IS; Andersen F; Bergh S; Bettella F; Bjornsson S; Brækhus A; Bråthen G; de Leeuw C; Desikan RS; Djurovic S; Dumitrescu L; Fladby T; Hohman TJ; Jonsson PV; Kiddle SJ; Rongve A; Saltvedt I; Sando SB; Selbæk G; Shoai M; Skene NG; Snaedal J; Stordal E; Ulstein ID; Wang Y; White LR; Hardy J; Hjerling-Leffler J; Sullivan PF; van der Flier WM; Dobson R; Davis LK; Stefansson H; Stefansson K; Pedersen NL; Ripke S; Andreassen OA; Posthuma D
    Nat Genet; 2019 Mar; 51(3):404-413. PubMed ID: 30617256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Evidence Supporting a Causal Role of Depression in Alzheimer's Disease.
    Harerimana NV; Liu Y; Gerasimov ES; Duong D; Beach TG; Reiman EM; Schneider JA; Boyle P; Lori A; Bennett DA; Lah JJ; Levey AI; Seyfried NT; Wingo TS; Wingo AP
    Biol Psychiatry; 2022 Jul; 92(1):25-33. PubMed ID: 35177243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease risk SNPs show no strong effect on miRNA expression in human lymphoblastoid cell lines.
    Wohlers I; Schulz C; Kilpert F; Bertram L
    Neurobiol Aging; 2020 Feb; 86():202.e1-202.e3. PubMed ID: 31685236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
    Jiang S; Yang W; Qiu Y; Chen HZ;
    Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis.
    Wingo AP; Liu Y; Gerasimov ES; Gockley J; Logsdon BA; Duong DM; Dammer EB; Robins C; Beach TG; Reiman EM; Epstein MP; De Jager PL; Lah JJ; Bennett DA; Seyfried NT; Levey AI; Wingo TS
    Nat Genet; 2021 Feb; 53(2):143-146. PubMed ID: 33510477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.